// App-Quantinova.ai

BSH19‐PO‐121 : Reversible Reduced Perforin expression in HLH secondary to Salmonella and Rotavirus enteritis

Researchers

Presenter

  • C. Horgan

Principal Investigators

  • J. Patel

  • M. Pavon-Mengual

  • Y.L.T. Chan

  • J. Motwani

Medical Centers

  • Department of Haematology, Birmingham Childrens Hospital, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Hemophagocytic lymphohistiocytosis

  • Hematology-oncology disease

  • Solid malignancies

Biomarkers

  • Perforin 1

  • Cluster of Differentiation 25

  • Lactate dehydrogenase

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Cyclosporine A

  • cefotaxime

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved